As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. When this issue went to press, the U.S. had the most cases of COVID-19...
Consuming Sucralose with Carbohydrates May Impair Insulin Sensitivity, Study Finds
Consuming sucralose-sweetened beverages with carbohydrates may impair insulin sensitivity, according to a study recently published in Cell Metabolism. Researchers led by Dana M. Small, PhD, director of the Modern Diet and Physiology Research Center at Yale University in New Haven, Conn., point out that there is still significant controversy surrounding the effects of no- or...
Heart Attack, Stroke Risk Declines among People with Diabetes
Two-decade study shows overall mortality risk remains higher than general population The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in The Journal of Clinical...
Older Men with Sarcopenia Are More Likely to Develop Diabetes over Time
New findings point to age-related muscle loss as a contributing factor to diabetes in the elderly Older men who have lower lean body mass as they age are more prone to developing diabetes, while similar findings were not found in older women, according to a new study published in the Journal of the Endocrine Society. ...
Revised ADA Guidelines Include SGLT2 Inhibitors for Type 2 Diabetes Patients
SGLT2 inhibitors were designed to lower glucose, but clinical trials uncovered unexpected cardiovascular and renal benefits. Updated guidelines from the American Diabetes Association now recommends SGLT2 inhibitors in type 2 diabetes patients to lower glucose. The evidence is clear that SGLT2 inhibitors should be added to the drug regimen of many type 2 diabetes patients,...
Two years after Medicare began covering the use of continuous glucose monitors by seniors, the advantages are becoming clear. However, patient education on the proper use of these systems is vital to their success. Some two years after Medicare began covering the use of continuous glucose monitors (CGM), seniors are increasingly reporting benefits, and a...
Untapped Resources: Improving the Practice of Medicine in the Age of Big Data
Patients and providers generate incredible amounts of data every day. Can it be put to better use in individualizing care? Endocrine News looks out how using information that already exists could dramatically improve patient care as well as scientific research. Love ’em or hate ’em, there could be gold in those electronic health records. The University...
Diabetes Drug Reduces Complications of Long-Term Steroid Therapy
A drug used to treat type 2 diabetes could offer a simple and cheap solution to reduce dangerous side effects of steroid treatment, new research from Queen Mary University of London suggests. The phase 2 clinical trial, funded by Barts Charity, looked at the effects of the diabetes drug metformin on patients currently receiving high...
